Our Strategy

At Success Charity, we recognise that there is a strong focus on the early diagnosis and treatment of childhood brain tumours, but that little attention is paid to the needs of the growing community of survivors. We want to redress the balance.

Our strategy is clear: We focus on life after cure. 

Support

Children who survive brain tumours need support medically, educationally, physically, psychologically and socially. The journey to recovery can be very hard. As well as the serious physical consequences of treatment, survivors often feel socially alienated and unable to thrive emotionally.

We equip: We support survivors to re-adapt and work to improve their health and quality of life as they grow and develop into maturity.

We connect: We aim to create a circle of supportive professional, family, and peer to peer networks, through formal mentoring, informal events, conferences and a vibrant online community.

We assist: We seek to develop pathways to improve life chances and mental well-being through by building dedicated resources in areas relating to neuro-disability, hormonal disorders, vision, hearing and learning impairments.

Research

Most brain tumour survivors experience significant and severely life limiting ‘late effects’ which start with the tumour and are aggravated by treatment and failed rehabilitation. Understanding the causes of each, which treatments are most implicated, and how we might avoid them, will help oncologists and neurosurgeons tailor their therapies, creating kinder treatments. 

Our research efforts are aimed at attaining a deeper understanding of the unrecognised yet treatable consequences of brain injury after tumours and treatments. 

We advocate: We want to contribute internationally across interdisciplinary boundaries to report on clinical need, best practice guidance and initiatives to improve outcomes for children and young people diagnosed with a brain tumour.

We research: We seed-fund academic PhD programmes to study and better understand the long term, life limiting effects of different types of tumours and treatments

We invest: We want to establish dedicated multidisciplinary teams to undertake clinical research into long term outcomes to provide longevity of service to support survivors.